rs1126642

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002055.5(GFAP):​c.883G>A​(p.Asp295Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0421 in 1,613,504 control chromosomes in the GnomAD database, including 1,847 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.036 ( 152 hom., cov: 33)
Exomes 𝑓: 0.043 ( 1695 hom. )

Consequence

GFAP
NM_002055.5 missense

Scores

4
9
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 6.17

Publications

24 publications found
Variant links:
Genes affected
GFAP (HGNC:4235): (glial fibrillary acidic protein) This gene encodes one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
GFAP Gene-Disease associations (from GenCC):
  • Alexander disease
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • Alexander disease type II
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003569454).
BP6
Variant 17-44911695-C-T is Benign according to our data. Variant chr17-44911695-C-T is described in ClinVar as Benign. ClinVar VariationId is 66509.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.133 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GFAPNM_002055.5 linkc.883G>A p.Asp295Asn missense_variant Exon 5 of 9 ENST00000588735.3 NP_002046.1
GFAPNM_001363846.2 linkc.883G>A p.Asp295Asn missense_variant Exon 5 of 10 NP_001350775.1
GFAPNM_001242376.3 linkc.883G>A p.Asp295Asn missense_variant Exon 5 of 7 NP_001229305.1
GFAPNM_001131019.3 linkc.883G>A p.Asp295Asn missense_variant Exon 5 of 8 NP_001124491.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GFAPENST00000588735.3 linkc.883G>A p.Asp295Asn missense_variant Exon 5 of 9 1 NM_002055.5 ENSP00000466598.2

Frequencies

GnomAD3 genomes
AF:
0.0356
AC:
5419
AN:
152234
Hom.:
147
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0223
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0279
Gnomad ASJ
AF:
0.0478
Gnomad EAS
AF:
0.141
Gnomad SAS
AF:
0.0602
Gnomad FIN
AF:
0.0140
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0393
Gnomad OTH
AF:
0.0239
GnomAD2 exomes
AF:
0.0454
AC:
11291
AN:
248574
AF XY:
0.0458
show subpopulations
Gnomad AFR exome
AF:
0.0211
Gnomad AMR exome
AF:
0.0417
Gnomad ASJ exome
AF:
0.0461
Gnomad EAS exome
AF:
0.143
Gnomad FIN exome
AF:
0.0129
Gnomad NFE exome
AF:
0.0373
Gnomad OTH exome
AF:
0.0353
GnomAD4 exome
AF:
0.0428
AC:
62509
AN:
1461152
Hom.:
1695
Cov.:
33
AF XY:
0.0428
AC XY:
31148
AN XY:
726966
show subpopulations
African (AFR)
AF:
0.0198
AC:
663
AN:
33476
American (AMR)
AF:
0.0428
AC:
1915
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0454
AC:
1184
AN:
26106
East Asian (EAS)
AF:
0.147
AC:
5848
AN:
39686
South Asian (SAS)
AF:
0.0566
AC:
4885
AN:
86236
European-Finnish (FIN)
AF:
0.0145
AC:
768
AN:
52992
Middle Eastern (MID)
AF:
0.0209
AC:
120
AN:
5740
European-Non Finnish (NFE)
AF:
0.0401
AC:
44585
AN:
1111830
Other (OTH)
AF:
0.0421
AC:
2541
AN:
60376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.433
Heterozygous variant carriers
0
3525
7051
10576
14102
17627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1802
3604
5406
7208
9010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0356
AC:
5428
AN:
152352
Hom.:
152
Cov.:
33
AF XY:
0.0349
AC XY:
2603
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0223
AC:
926
AN:
41590
American (AMR)
AF:
0.0286
AC:
437
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0478
AC:
166
AN:
3470
East Asian (EAS)
AF:
0.141
AC:
731
AN:
5178
South Asian (SAS)
AF:
0.0598
AC:
289
AN:
4830
European-Finnish (FIN)
AF:
0.0140
AC:
149
AN:
10626
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0393
AC:
2677
AN:
68032
Other (OTH)
AF:
0.0237
AC:
50
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
276
552
829
1105
1381
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0403
Hom.:
609
Bravo
AF:
0.0369
TwinsUK
AF:
0.0429
AC:
159
ALSPAC
AF:
0.0444
AC:
171
ESP6500AA
AF:
0.0223
AC:
98
ESP6500EA
AF:
0.0377
AC:
324
ExAC
AF:
0.0447
AC:
5422
Asia WGS
AF:
0.0950
AC:
331
AN:
3478
EpiCase
AF:
0.0358
EpiControl
AF:
0.0311

ClinVar

Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5Other:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Epithelial Biology; Institute of Medical Biology, Singapore
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Oct 26, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 14, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.24
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.81
.;D;.;.;.;.;.;D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.98
D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0036
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Uncertain
2.5
.;M;.;.;M;M;.;.
PhyloP100
6.2
PrimateAI
Uncertain
0.63
T
PROVEAN
Uncertain
-2.7
.;.;D;.;D;.;.;.
REVEL
Uncertain
0.51
Sift
Pathogenic
0.0
.;.;D;.;D;.;.;.
Sift4G
Pathogenic
0.0010
.;.;D;.;D;.;D;.
Polyphen
0.99
.;D;.;.;.;.;.;.
Vest4
0.36, 0.39, 0.21
MPC
1.2
ClinPred
0.015
T
GERP RS
3.4
PromoterAI
-0.018
Neutral
Varity_R
0.83
gMVP
0.96
Mutation Taster
=72/28
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1126642; hg19: chr17-42989063; COSMIC: COSV53650087; COSMIC: COSV53650087; API